Abbott Laboratories vs. Silence Therapeutics Plc American Depository Share
ABT
Abbott Laboratories
$99.60 +1.13%
VS SLNSilence Therapeutics Plc American Depository Share
$12.25 +0.41%
Abbott Laboratories and Silence Therapeutics Plc American Depository Share are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | SLN | |
|---|---|---|
| Market Cap | $172.35 billion | $758.28 million |
| Revenue (TTM) | — | $615,000 |
| Net Income (TTM) | — | $-59,953,000 |
ABT leads on 1 of 1 size & scale factors.
Valuation
| ABT | SLN | |
|---|---|---|
| Price / Book | — | 19.71 |
| Price / Sales | — | 1232.98 |
ABT and SLN split the valuation factors evenly.
Profitability
| ABT | SLN | |
|---|---|---|
| Net Margin | — | -9748.46% |
| Return on Equity | — | -155.84% |
ABT and SLN split the profitability factors evenly.
Dividend
| ABT | SLN | |
|---|---|---|
| Dividend Yield | 2.53% | — |
ABT and SLN split the dividend factors evenly.
Risk & Sentiment
| ABT | SLN | |
|---|---|---|
| Short Interest | 0.57% | 0.00% |
SLN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, SLN overview, SLN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.